Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
10.03
+0.55 (5.80%)
Nov 28, 2025, 4:00 PM EST - Market closed
Biohaven Employees
Biohaven had 256 employees as of December 31, 2024. The number of employees increased by 17 or 7.11% compared to the previous year.
Employees
256
Change (1Y)
17
Growth (1Y)
7.11%
Revenue / Employee
n/a
Profits / Employee
-$3,047,305
Market Cap
1.33B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 256 | 17 | 7.11% |
| Dec 31, 2023 | 239 | 37 | 18.32% |
| Dec 31, 2022 | 202 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BHVN News
- 8 days ago - Biohaven's Chief Accounting Officer Scooped Up 17,000 Shares. Is the Stock a Buy? - The Motley Fool
- 15 days ago - Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M - PRNewsWire
- 16 days ago - Biohaven Q3 Earnings: Falling Back To Earth With A Thud - Seeking Alpha
- 16 days ago - FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 16 days ago - Biohaven Announces Pricing of $175 Million Public Offering of Common Shares - PRNewsWire
- 17 days ago - Biohaven Announces Proposed Public Offering of Common Shares - PRNewsWire
- 18 days ago - Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments - PRNewsWire
- 23 days ago - Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection - Benzinga